A new indication for omalizumab is prompting clinicians to adjust their approach to oral food challenges, but experts ...

Current guidelines suggest limiting diagnostic testing for chronic spontaneous urticaria when no clear cause is suspected, though biomarkers and biopsies are emerging as tools to predict treatment ...